Abiopharma

🔍 Jewell Marcus (Executive)

Company: Cellebrite DI Ltd. (CLBT)

Report Date: 2026-08-12

Detailed Transactions and Holdings:

• Sold 411 shares of Ordinary shares, par value NIS 0.00001 at $16.0678 per share (Direct)
  Date: 2026-08-12 | Code: S | equity_swap_involved: 0 | shares_owned_after: 439,690.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: The shares reported as disposed herein were granted on February 11, 2025, in the form of restricted stock units ("RSUs"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.0086 to $16.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.